Treating the whole glaucoma spectrum: A new treatment approach is required
Br J Clin Pharmacol
.
2021 Mar;87(3):717-718.
doi: 10.1111/bcp.14507.
Epub 2020 Aug 9.
Authors
Timothy E Yap
1
2
,
M Francesca Cordeiro
1
2
3
Affiliations
1
The Western Eye Hospital, Imperial College Healthcare NHS Trust (ICHNT), London, UK.
2
The Imperial College Ophthalmology Research Group (ICORG), Imperial College, London, UK.
3
Glaucoma and Retinal Neurodegeneration Group, Department of Visual Neuroscience, UCL Institute of Ophthalmology, London, UK.
PMID:
33657769
DOI:
10.1111/bcp.14507
No abstract available
Keywords:
biomarkers; glaucoma; neurodegeneration; neuroprotection; retinal ganglion cells.
MeSH terms
Glaucoma* / drug therapy
Humans
Neuroprotective Agents*
Substances
Neuroprotective Agents